No Data
No Data
MediWound to Report Fourth Quarter and Full Year 2024 Financial Results
This CoStar Group Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday
Craig-Hallum Initiates MediWound(MDWD.US) With Buy Rating, Announces Target Price $39
Craig-Hallum Initiates Coverage On MediWound With Buy Rating, Announces Price Target of $39
MediWound Announces Phase III CIDS Publication on NexoBrid for Pediatric Burn Care
MediWound to Present at the 45th Annual TD Cowen Health Care Conference